Transcend Therapeutics clinical trials
Acquired by Otsuka Holdings Co., Ltd., 2026 · source ↗
The registry lists 7 studies whose lead sponsor is Transcend Therapeutics. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 23, 2026.
Before and after it joined Otsuka Holdings Co., Ltd.
- First submitted before Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.
- 4
- First submitted after Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.
- 0
- Unclear, or no submission date
- 3
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Transcend Therapeutics7 studies
Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. All Otsuka Holdings Co., Ltd. studies →
- An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSDRecruitingNCT07836647Phase 3
Sponsor listed in the registry: Transcend Therapeutics · Unclear whether first submitted before or after Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.
- An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)RecruitingNCT07456696Phase 3
Sponsor listed in the registry: Transcend Therapeutics · Unclear whether first submitted before or after Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.
- An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSDEnrolling by invitationNCT07670702Phase 3
Sponsor listed in the registry: Transcend Therapeutics · Unclear whether first submitted before or after Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.
- A Study to Assess the Use of Methylone in the Treatment of PTSDCompletedNCT05741710Phase 1/2
Sponsor listed in the registry: Transcend Therapeutics · First submitted before Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.
- An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSDCompletedNCT06237426Phase 2
Sponsor listed in the registry: Transcend Therapeutics · First submitted before Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.
- An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSDCompletedNCT06215261Phase 2
Sponsor listed in the registry: Transcend Therapeutics · First submitted before Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.
- A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy SubjectsCompletedNCT06303648Phase 1
Sponsor listed in the registry: Transcend Therapeutics · First submitted before Transcend Therapeutics became part of Otsuka Holdings Co., Ltd.